High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up

Primary mediastinal B-cell lymphoma (PMBL) is currently curable in 85–95% of patients. Treatment regimens frequently used include RCHOP ± radiotherapy, DAEPOCH-R, or occasionally more intensive protocols. Here we present results of treatment of 124 patients with PMBL over a period between 2004 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Romejko-Jarosinska, Joanna, Ostrowska, Beata, Dabrowska-Iwanicka, Anna, Domanska-Czyz, Katarzyna, Rymkiewicz, Grzegorz, Paszkiewicz-Kozik, Ewa, Konecki, Robert, Borawska, Anna, Druzd-Sitek, Agnieszka, Lampka, Elzbieta, Osiadacz, Wlodzimierz, Osowiecki, Michal, Popławska, Lidia, Swierkowska, Monika, Targonski, Lukasz, Tajer, Joanna, Lapinska, Grazyna, Smorczewska, Malwina, Walewski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217998/
https://www.ncbi.nlm.nih.gov/pubmed/35732790
http://dx.doi.org/10.1038/s41598-022-14067-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217998/
https://www.ncbi.nlm.nih.gov/pubmed/35732790
http://dx.doi.org/10.1038/s41598-022-14067-3

Ejemplares similares